Mark Carthy, Orion Healthcare Equity

Mark Carthy, Managing Partner of Orion Equity Partners, invests in early-stage healthcare and biotechnology ventures developing products. See contact routes.

About Mark Carthy

Mark Carthy, Managing Partner of Orion Equity Partners, invests in early-stage healthcare and biotechnology ventures developing products for major medical needs, with typical check sizes ranging from $1–5 million. His notable portfolio includes Solexa (acquired by Illumina for ~$600M), PowderMed (acquired by Pfizer), and AnTolRx, where he serves as CEO and director. Carthy’s distinctive thesis emphasizes capital-efficient value creation for science-driven health technologies that achieve strategic exits.

Mark Carthy at a glance

Role
Managing Director
Organization
Orion Healthcare Equity Partners
Location
Boston, Massachusetts, United States
Investor type
Venture Capital

Frequently asked about Mark Carthy

What does Mark Carthy invest in?
We have not verified a stated sector or stage focus for Mark Carthy at Orion Healthcare Equity Partners (Boston, Massachusetts, United States). The profile lists the organization, location and investors we track alongside them.
How do I contact Mark Carthy?
Mark Carthy's published profile links (website, LinkedIn or X where available) are listed on the StartupFundraising.com investor profile.
Where is Mark Carthy based?
Mark Carthy is based in Boston, Massachusetts, United States.

Every field above is read from the StartupFundraising investor directory — disclosed location, recorded investments and stated focus — and re-checked as filings arrive. Founders pair it with investors in Boston when building a target list.

Investors similar to Mark Carthy (20)

Browse related investor lists (2)

Compare Mark Carthy (8)

Investors like Mark Carthy · Full investor directory · Investor access · Company funding database